Are vaccines in pregnancy linked to infant mortality and hospitalization? (VIDEO)

Article

For Contemporary Pediatrics, Dr Bobby Lazzara discusses a case control study published in Pediatrics that looked at whether associations existed between mother receiving influenza and/or Tetanus, diphtheria, and acellular pertussis vaccinations during pregnancy and infant hospitalization or death occurring in the first 6 months of life.

For Contemporary Pediatrics, Dr Bobby Lazzara discusses a case control study published in Pediatrics that looked at whether associations existed between mother receiving influenza and/or Tetanus, diphtheria, and acellular pertussis vaccinations during pregnancy and infant hospitalization or death occurring in the first 6 months of life.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Tina Tan, MD
Robert Frenck, MD
Stephanie Anne Deutsch, MD, MS, MSCR, FAAP
Erica Prochaska, MD
Related Content
ACIP updates: Committee votes 5-2 to recommend clesrovimab to protect against RSV | Image Credit: © JJHVEPhoto - © JHVEPhoto - stock.adobe.com.

ACIP updates: Committee recommends clesrovimab for RSV, reaffirms routine influenza vaccination

Joshua Fitch, Senior Editor
June 26th 2025
Article

The final recommendation sign off decision will go to HHS secretary Robert F. Kennedy Jr.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

Miranda Hester
August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

Donna Hallas

PNP Perspective: Focus on the positive outcomes of accepting vaccines

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN
June 25th 2025
Article

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on how PNPs can implement evidence-based strategies to encourage parents to vaccinate their children.

What Omicron could mean for the pandemic

What Omicron could mean for the pandemic

Miranda Hester
January 7th 2022
Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

Bavarian Nordic initiates trial of chikungunya vaccine in children aged 2-11 years | Image Credit: © ImageKing - © ImageKing - stock.adobe.com.

Bavarian Nordic initiates trial of chikungunya vaccine in children aged 2-11 years

Joshua Fitch, Senior Editor
June 13th 2025
Article

Currently, Vimkunya is FDA-approved for use among individuals aged 12 years and older.

FDA approves clesrovimab to protect infants during first RSV season | Image Credit: Contemporary Pediatrics

FDA approves clesrovimab to protect infants during first RSV season

Joshua Fitch, Senior Editor
June 9th 2025
Article

The BLA for clesrovimab was based on results demonstrated in the phase 2b/3 CLEVER trial among healthy pre-term and full-term infants.

© 2025 MJH Life Sciences

All rights reserved.